Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Invaplex 50 vaccine for shigellosis
NCT00485134Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- May 2007
- Primary completion
- Jul 2009
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Invaplex 50 in shigellosis, sponsored by U.S. Army Medical Research and Development Command. Started May 2007; status: completed.
02
Drugs
Invaplex 50
03
Conditions
shigellosis
Beyond the preview
Go deeper on NCT00485134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485134.